Meeting
2023 ASCO Annual Meeting
The association between systemic anticancer therapy (SACT) at the end of life (EOL) and acute care use among patients treated at oncology practices participating in the Oncology Care Model (OCM).
Authors
Maureen Canavan
Yale School of Medicine, New Haven, CT
Maureen Canavan , Karna Sheth , Jeffrey A. Scott , Sarah Westvold , Kerin B. Adelson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Quality Improvement
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6580)
DOI
10.1200/JCO.2023.41.16_suppl.6580
Abstract #
6580
Poster Bd #
72
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Systemic anti-cancer therapy and cost at end of life: A SEER Medicare analysis.
First Author: Kerin B. Adelson
Poster
2021 ASCO Quality Care Symposium
Trends in end-of- life (EOL) systemic oncologic treatment in contemporary clinical practice: Insights from real-world data.
First Author: Maureen Canavan
Poster
2021 ASCO Quality Care Symposium
Differences by race in systemic oncologic end-of-life (EOL) care among patients with cancer.
First Author: Kerin B. Adelson
Poster
2019 ASCO Annual Meeting
Is there a shift in use of subacute rehabilitation (SAR) instead of hospice referral since immunotherapy became available?
First Author: Jonathan Yeh